首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Pharmacokinetic comparisons of single herb extract of Fufang Danshen preparation with different combinations of its constituent herbs in rats
【24h】

Pharmacokinetic comparisons of single herb extract of Fufang Danshen preparation with different combinations of its constituent herbs in rats

机译:复方丹参制剂单药提取物与组成成分不同组合的大鼠药动学比较

获取原文
获取原文并翻译 | 示例
       

摘要

Salvianolic acid B (SAB), tanshinone IIA (TS), ginsenoside Rb 1 (Rb 1), ginsenoside Rg 1 (Rg 1) and notoginsenoside R 1 (R 1) are major active ingredients of Fufang Danshen preparation (FDP) for its protective effects on myocardial ischemia. This study investigated the pharmacokinetics of marker compounds after oral administration of single herb extract and different combinations of constitutional herbs in FDP, and explored potential herb-herb interactions among the ingredients in the multi-herb medicine. The pharmacokinetics study on the target compounds in rat plasma was performed using an optimal ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry (UPLC-ESI-MS/MS) coupled with protein precipitation method. There were no statistically significant differences in pharmacokinetic parameters of SAB, TS, Rb 1, Rg 1 and R 1 between single Radix Salvia miltiorrhiza (S. miltiorrhiza) or Radix Panax notoginsen (P. notoginseng) extract and combination treatment. While, in comparison with oral administration of P. notoginseng extract alone, the pharmacokinetic parameters (C max, AUC 0-72h, AUC 0-∞, Cl, V), particularly for Rb 1 and Rg 1, were significantly different after oral administration P. notoginseng extract with addition of borneol (p0.05). The AUC 0-72h values of Rb 1 and Rg 1 were significantly increased 1.3-fold and 1.6-fold, respectively, after P. Notoginsen extract co-administered with borneol. The results showed that herb-herb interactions may be accounting for the different pharmacokinetic behaviors of active constituents administered in compound prescriptions versus in single-herb extracts, however, which were not significant in most cases.
机译:复方丹参制剂(FDP)的主要活性成分是丹酚酸B(SAB),丹参酮IIA(TS),人参皂苷Rb 1(Rb 1),人参皂苷Rg 1(Rg 1)和三七皂苷R 1(R 1)。对心肌缺血的影响。这项研究调查了在FDP中口服单一草药提取物和不同组成的草药后口服的标志物化合物的药代动力学,并探讨了多草药中各成分之间潜在的草药-草药相互作用。使用最佳超高效液相色谱-电喷雾串联质谱(UPLC-ESI-MS / MS)结合蛋白质沉淀法对大鼠血浆中的目标化合物进行药代动力学研究。单丹参或三七提取物和联合治疗的SAB,TS,Rb 1,Rg 1和R 1的药代动力学参数在统计学上无显着差异。尽管与口服三七提取物相比,口服后药代动力学参数(C max,AUC 0-72h,AUC0-∞,Cl,V),特别是对于Rb 1和Rg 1而言,显着不同添加冰片的三七提取物(p <0.05)。 P. Notoginsen提取物与冰片共同施用后,Rb 1和Rg 1的AUC 0-72h值分别显着增加了1.3倍和1.6倍。结果表明,药草-药草相互作用可能解释了复合处方药与单药草提取物中活性成分的不同药代动力学行为,但是,在大多数情况下这并不重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号